search
Front > News

Teva, IBM team to seek big data health solutions

Teva picture: Bloomberg
Teva picture: Bloomberg
10 Sep, 2015 17:36
שלח תגובה במיילGlobes correspondent

Teva hopes to develop treatments for chronic conditions using the Watson Health Cloud’s cognitive computing capabilities.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and IBM announced a new partnership on Thursday. The Israeli pharmaceutical giant was selected as the first Foundational Life Sciences Partner for the Watson Health Cloud program, gaining access to its big data capabilities.

IBM’s Watson is the first commercially available cognitive computing platform that can process natural language queries and crunch vast amounts of data. Teva plans to use the global technology platform to design treatments for “unmet and emerging patients” including millions of people who suffer from chronic conditions like asthma, migraine, and pain.

“By building on the Watson Health Cloud, we believe Teva will be in a unique position to put the best information and insights in the hands of physicians, care teams and patients, to empower treatment optimization for individuals and populations across the spectrum of acute and chronic conditions,” said Teva SVP Guy Hadari.

The two firms will also create a joint Teva-IBM Research team that will use big data to model diseases and potential therapeutic treatments.

“Teva’s pioneering digital health vision, reach across global markets, extensive portfolio of medicines and significant industry experience make them a preferred life science ecosystem partner for the Watson Health Cloud,” said IBM Watson SVP Mike Rhodin.

Teva, as one of the largest pharmaceutical companies in the world, will help IBM to improve the Watson Health Cloud’s capabilities and its integration with existing Watson Health ecosystem partners. The Israeli firm expects its work with IBM on the long-range platform to lead to the development of solutions designed by the analysis of real world evidence.

“Watson holds promise to provide Teva with better insights, real-time feedback and options for clinicians to consider to improve patient care,” added Teva’s Hadari.

Published by Globes [online], Israel business news - www.globes-online.com - on September 9, 2015

© Copyright of Globes Publisher Itonut (1983) Ltd. 2015

Teva picture: Bloomberg
Teva picture: Bloomberg
Emiliano Calemzuk credit: PR CEO and "investor group" buying out Reshet 13

CEO Emiliano Calemzuk and the other investors will hold 74% of the television channel, while Len Blavatnik’s Access Industries and WBD will remain with 26%.

Inflation credit: Tali Bogdanovsky Unexpectedly low February CPI reading cuts inflation

While inflation in Israel in the 12 months to the end of February 2025 is lower than forecast, housing prices continue to rise.

Yitzhak Tshuva credit: Gidon Levy and Tali Bogdanovsky Competition Authority allows Delek takeover of Isracard

The Competition Authority is considered the easier of the two regulatory hurdles that the deal must overcome, the other being the Supervisor of Banks.

David Amsalem credit Noam Moskowitz, Knesset Spokesperson's Office Rafael to pay state NIS 444m dividend

The minister in charge of the Government Companies Authority, David Amsalem, has approved the payment by the defense company.

Barak MX air defense system credit: IAI IAI profit jumps 55%

Israel Aerospace Industries posted a net profit of $493 million for 2024, and ended the year with an all-time high orders backlog of $25 billion.

A TSG system in tactical use credit: PR TSG signs cooperation agreement with US defense co

The agreement includes the integration of TSG's advanced technologies into sensor-based defense systems, which will be integrated into the operational systems of US defense units.

Bria CEO Yair Adato credit: Kseniia Poliak Israeli visual generative AI co Bria raises $40m

Bria’s Visual Generative AI platform empowers businesses to create predictable, controllable, and on-brand content that aligns with their visual language.

Amnon Shashua and Aviram Ziv credit: Eyal Izhar OrCam stymied by investor dispute with Shashua

Demands by institutional investors are blocking the visual and hearing impairment device developer's recovery plan.

Work on the Green Line credit: Bar Lavi Egged wins tender to operate TA light rail Purple, Green Lines

NTA awarded the tender to Egged, which already operates the Red Line, despite government ministry opposition to one operator for the entire network.

Gabi Seroussi illustration: Gil Gibli Board chooses Seroussi as IAI chair as Erdan freezes candidacy

Israel Aerospace Industries board chose Gabi Seroussi as chair even though he did not to go through the preliminary process of the Government Companies Authority appointments review committee.

Bavli Park penthouse credit: Eyal Tagar Tel Aviv Park Bavli penthouse sells for NIS 43m

A 44th floor penthouse in one of the two towers in businessman Yitzhak Tshuva's Park Bavli project has been bought by an Israeli businessperson.

El Al aircraft credit: Yoav Yaari El Al pilots receive nearly NIS 250,000 bonus each

Thanks to the agreements signed with the unions in 2018, El Al's employees as well as senior management share in last year's success.

Pentera CEO Amitai Ratzon credit: Eyal Izhar Israeli security validation co Pentera raises $60m

Pentera's platform enables security teams to analyze complete attack paths, identify root causes, and prioritize remediation for effective risk reduction.

Tel Aviv credit: Shutterstock Supply of unsold new homes hits record

Israel's real estate market is sliding into recession with 78,000 unsold new apartments in January, the Central Bureau of Statistics reports.

D&B chairman Doron Cohen and Meitar partner Dan Geva Meitar reclaims title of Israel's biggest law firm

Meitar has first place with 537 lawyers, followed by Herzog Fox Neeman with 512 lawyers, according to the latest Dun's 100 rankings.

First International Bank of Israel CEO Eli Cohen credit: Eyal Toueg First Int'l posts top return on equity

First International Bank of Israel's return on equity in 2024 was 19%, the highest among Israel's banks.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018